Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 356

1.

Molecular Study of Long-Term Survivors of Glioblastoma by Gene-Targeted Next-Generation Sequencing.

Cantero D, Rodríguez de Lope Á, Moreno de la Presa R, Sepúlveda JM, Borrás JM, Castresana JS, D'Haene N, García JF, Salmon I, Mollejo M, Rey JA, Hernández-Laín A, Meléndez B.

J Neuropathol Exp Neurol. 2018 Aug 1;77(8):710-716. doi: 10.1093/jnen/nly048.

PMID:
30010995
2.

Substance use disorders in patients with intellectual disability admitted to psychiatric hospitalisation.

Salavert J, Clarabuch A, Fernández-Gómez MJ, Barrau V, Giráldez MP, Borràs J.

J Intellect Disabil Res. 2018 Jul 1. doi: 10.1111/jir.12514. [Epub ahead of print]

PMID:
29961996
3.

Tumor Surface Regularity at MR Imaging Predicts Survival and Response to Surgery in Patients with Glioblastoma.

Pérez-Beteta J, Molina-García D, Ortiz-Alhambra JA, Fernández-Romero A, Luque B, Arregui E, Calvo M, Borrás JM, Meléndez B, Rodríguez de Lope Á, Moreno de la Presa R, Iglesias Bayo L, Barcia JA, Martino J, Velásquez C, Asenjo B, Benavides M, Herruzo I, Revert A, Arana E, Pérez-García VM.

Radiology. 2018 Jul;288(1):218-225. doi: 10.1148/radiol.2018171051.

PMID:
29924716
4.

The economic burden of disease of epithelial ovarian cancer in Spain: the OvarCost study.

Delgado-Ortega L, González-Domínguez A, Borrás JM, Oliva-Moreno J, González-Haba E, Menjón S, Pérez P, Vicente D, Cordero L, Jiménez M, Simón S, Hidalgo-Vega Á, Moya-Alarcón C.

Eur J Health Econ. 2018 Jun 19. doi: 10.1007/s10198-018-0986-y. [Epub ahead of print]

PMID:
29922900
5.

Influence of age on variation in patterns of care in patients with rectal cancer in Catalonia (Spain).

Vernet R, Borras JM, Aliste L, Antonio M, Guarga A, Manchon-Walsh P.

Clin Transl Oncol. 2018 May 15. doi: 10.1007/s12094-018-1882-8. [Epub ahead of print]

PMID:
29766457
6.

The role of posttraumatic stress and posttraumatic growth on online information use in breast cancer survivors.

Casellas-Grau A, Sumalla EC, Lleras M, Vives J, Sirgo A, León C, Rodríguez A, Campos G, Valverde Y, Borràs JM, Ochoa C.

Psychooncology. 2018 May 8. doi: 10.1002/pon.4753. [Epub ahead of print]

PMID:
29740909
7.

Impact of mutational studies on the diagnosis and the outcome of high-risk myelodysplastic syndromes and secondary acute myeloid leukemia patients treated with 5-azacytidine.

Cabezón M, Bargay J, Xicoy B, García O, Borrás J, Tormo M, Marcé S, Pedro C, Valcárcel D, Jiménez MJ, Guàrdia R, Palomo L, Brunet S, Vall-Llovera F, Garcia A, Feliu E, Zamora L; CETLAM Group.

Oncotarget. 2018 Apr 10;9(27):19342-19355. doi: 10.18632/oncotarget.25046. eCollection 2018 Apr 10.

8.

Clinical Audit of the Radiotherapy Process in Rectal Cancer: Clinical Practice Guidelines and Quality Certification Do Not Avert Variability in Clinical Practice.

Torras MG, Canals E, Jurado-Bruggeman D, Marín-Borras S, Macià M, Jové J, Boladeras AM, Muñoz-Montplet C, Molero J, Picón C, Puigdemont M, Aliste L, Torrents A, Guedea F, Borras JM.

Transl Oncol. 2018 Jun;11(3):794-799. doi: 10.1016/j.tranon.2018.03.015. Epub 2018 Apr 26.

9.

Tumor Surface Regularity at MR Imaging Predicts Survival and Response to Surgery in Patients with Glioblastoma.

Pérez-Beteta J, Molina-García D, Ortiz-Alhambra JA, Fernández-Romero A, Luque B, Arregui E, Calvo M, Borrás JM, Meléndez B, Rodríguez de Lope Á, Moreno de la Presa R, Iglesias Bayo L, Barcia JA, Martino J, Velásquez C, Asenjo B, Benavides M, Herruzo I, Revert A, Arana E, Pérez-García VM.

Radiology. 2018 Apr 3:171051. doi: 10.1148/radiol.201171051. [Epub ahead of print]

PMID:
29613845
10.

Long-term crude probabilities of death among breast cancer patients by age and stage: a population-based survival study in Northeastern Spain (Girona-Tarragona 1985-2004).

Clèries R, Ameijide A, Buxó M, Martínez JM, Marcos-Gragera R, Vilardell ML, Carulla M, Yasui Y, Vilardell M, Espinàs JA, Borràs JM, Galceran J, Izquierdo À.

Clin Transl Oncol. 2018 Mar 6. doi: 10.1007/s12094-018-1852-1. [Epub ahead of print]

PMID:
29511947
11.

Germline promoter hypermethylation in BRCA1 and BRCA2 genes is not present in hereditary breast cancer patients.

Rodríguez-Balada M, Roig B, Melé M, Salvat M, Martorell L, Borràs J, Gumà J.

Clin Transl Oncol. 2018 Feb 5. doi: 10.1007/s12094-018-1837-0. [Epub ahead of print]

PMID:
29404838
12.

Geriatric assessment may help decision-making in elderly patients with inoperable, locally advanced non-small-cell lung cancer.

Antonio M, Saldaña J, Linares J, Ruffinelli JC, Palmero R, Navarro A, Arnaiz MD, Brao I, Aso S, Padrones S, Navarro V, González-Barboteo J, Borràs JM, Cardenal F, Nadal E.

Br J Cancer. 2018 Mar 6;118(5):639-647. doi: 10.1038/bjc.2017.455. Epub 2018 Jan 30.

PMID:
29381689
13.

[WebSurvCa: web-based estimation of death and survival probabilities in a cohort].

Clèries R, Ameijide A, Buxó M, Vilardell M, Martínez JM, Alarcón F, Cordero D, Díez-Villanueva A, Yasui Y, Marcos-Gragera R, Vilardell ML, Carulla M, Galceran J, Izquierdo Á, Moreno V, Borràs JM.

Gac Sanit. 2018 Jan 19. pii: S0213-9111(17)30306-0. doi: 10.1016/j.gaceta.2017.10.015. [Epub ahead of print] Spanish.

14.

Metabolomics reveals novel blood plasma biomarkers associated to the BRCA1-mutated phenotype of human breast cancer.

Roig B, Rodríguez-Balada M, Samino S, Lam EW, Guaita-Esteruelas S, Gomes AR, Correig X, Borràs J, Yanes O, Gumà J.

Sci Rep. 2017 Dec 19;7(1):17831. doi: 10.1038/s41598-017-17897-8.

15.

Revisiting the thiosemicarbazonecopper(II) reaction with glutathione. Activity against colorectal carcinoma cell lines.

García-Tojal J, Gil-García R, Fouz VI, Madariaga G, Lezama L, Galletero MS, Borrás J, Nollmann FI, García-Girón C, Alcaraz R, Cavia-Saiz M, Muñiz P, Palacios Ò, Samper KG, Rojo T.

J Inorg Biochem. 2018 Mar;180:69-79. doi: 10.1016/j.jinorgbio.2017.12.005. Epub 2017 Dec 8.

PMID:
29247869
16.

Managing cancer care through service delivery networks: The role of professional collaboration in two European cancer networks.

Prades J, Morando V, Tozzi VD, Verhoeven D, Germà JR, Borras JM.

Health Serv Manage Res. 2017 Jan 1:951484817745219. doi: 10.1177/0951484817745219. [Epub ahead of print]

PMID:
29239683
17.

Estimating the number of fractions by tumour site for European countries in 2012 and 2025: An ESTRO-HERO analysis.

Borras JM, Grau C, Corral J, Wong K, Barton MB, Ferlay J, Bray F, Lievens Y.

Radiother Oncol. 2018 Feb;126(2):198-204. doi: 10.1016/j.radonc.2017.11.009. Epub 2017 Nov 29.

PMID:
29198408
18.

Definition of a SNOMED CT pathology subset and microglossary, based on 1.17 million biological samples from the Catalan Pathology Registry.

Sanz X, Pareja L, Rius A, Rodenas P, Abdón N, Gálvez J, Esteban L, Escribà JM, Borràs JM, Ribes J.

J Biomed Inform. 2018 Feb;78:167-176. doi: 10.1016/j.jbi.2017.11.010. Epub 2017 Nov 20.

PMID:
29158204
19.

Factors Predicting Adherence to a Tailored-Dose Adjuvant Treatment on the Basis of Geriatric Assessment in Elderly People With Colorectal Cancer: A Prospective Study.

Antonio M, Carmona-Bayonas A, Saldaña J, Navarro V, Tebé C, Salazar R, Borràs JM.

Clin Colorectal Cancer. 2018 Mar;17(1):e59-e68. doi: 10.1016/j.clcc.2017.09.003. Epub 2017 Sep 28.

PMID:
29054805
20.

Predicting the cancer burden in Catalonia between 2015 and 2025: the challenge of cancer management in the elderly.

Clèries R, Ameijide A, Marcos-Gragera R, Pareja L, Carulla M, Vilardell ML, Esteban L, Buxó M, Espinàs JA, Puigdefàbregas A, Ribes J, Izquierdo A, Galceran J, Borrás JM.

Clin Transl Oncol. 2018 May;20(5):647-657. doi: 10.1007/s12094-017-1764-5. Epub 2017 Oct 12.

PMID:
29027110
21.

Summary statement on screening for prostate cancer in Europe.

Heijnsdijk EAM, Bangma CH, Borràs JM, de Carvalho TM, Castells X, Eklund M, Espinàs JA, Graefen M, Grönberg H, Lansdorp-Vogelaar I, Leeuwen PJV, Nelen V, Recker F, Roobol MJ, Vandenbulcke P, de Koning HJ.

Int J Cancer. 2018 Feb 15;142(4):741-746. doi: 10.1002/ijc.31102. Epub 2017 Oct 25.

PMID:
29023685
22.

Clinical relevance of histologic subtypes in locally advanced esophageal carcinoma treated with pre-operative chemoradiotherapy: Experience of a monographic oncologic centre.

Saigí M, Oliva M, Aliste L, Calvo M, Hormigo G, Serra Ò, Boladeras A, Farran L, Robles J, Creus G, Paúles MJ, Gornals JB, de Lama E, Borràs JM, Sala N, Galán M.

PLoS One. 2017 Sep 20;12(9):e0184737. doi: 10.1371/journal.pone.0184737. eCollection 2017.

23.

Improving radiation oncology through clinical audits: Introducing the IROCA project.

Torras MG, Fundowicz M, Aliste L, Asensio E, Boladeras AM, Borràs JM, Carvalho L, Castro C, Deantonio L, Konstanty E, Krengli M, Kruszyna M, Lencart J, Macià M, Marín S, Muñoz-Montplet C, Pisani C, Pinto D, Puigdemont M, Guedea F, Aguiar A, Milecki P, Malicki J.

Rep Pract Oncol Radiother. 2017 Sep-Oct;22(5):408-414. doi: 10.1016/j.rpor.2017.07.004. Epub 2017 Aug 11.

PMID:
28831281
24.

Towards the centralization of digestive oncologic surgery: changes in activity, techniques and outcome.

Tebé C, Pla R, Espinàs JA, Corral J, Puigdomenech E, Borràs JM, Pons JMV, Espallargues M.

Rev Esp Enferm Dig. 2017 Sep;109(9):634-642. doi: 10.17235/reed.2017.4710/2016.

25.

Assessing predicted age-specific breast cancer mortality rates in 27 European countries by 2020.

Clèries R, Rooney RM, Vilardell M, Espinàs JA, Dyba T, Borras JM.

Clin Transl Oncol. 2018 Mar;20(3):313-321. doi: 10.1007/s12094-017-1718-y. Epub 2017 Jul 19.

PMID:
28726040
26.

Adipose-Derived Fatty Acid-Binding Proteins Plasma Concentrations Are Increased in Breast Cancer Patients.

Guaita-Esteruelas S, Saavedra-García P, Bosquet A, Borràs J, Girona J, Amiliano K, Rodríguez-Balada M, Heras M, Masana L, Gumà J.

Oncologist. 2017 Nov;22(11):1309-1315. doi: 10.1634/theoncologist.2016-0483. Epub 2017 Jul 12.

27.

Geriatric Assessment Predicts Survival and Competing Mortality in Elderly Patients with Early Colorectal Cancer: Can It Help in Adjuvant Therapy Decision-Making?

Antonio M, Saldaña J, Carmona-Bayonas A, Navarro V, Tebé C, Nadal M, Formiga F, Salazar R, Borràs JM.

Oncologist. 2017 Aug;22(8):934-943. doi: 10.1634/theoncologist.2016-0462. Epub 2017 May 9.

PMID:
28487465
28.

An International Collaborative Standardizing a Comprehensive Patient-Centered Outcomes Measurement Set for Colorectal Cancer.

Zerillo JA, Schouwenburg MG, van Bommel ACM, Stowell C, Lippa J, Bauer D, Berger AM, Boland G, Borras JM, Buss MK, Cima R, Van Cutsem E, van Duyn EB, Finlayson SRG, Hung-Chun Cheng S, Langelotz C, Lloyd J, Lynch AC, Mamon HJ, McAllister PK, Minsky BD, Ngeow J, Abu Hassan MR, Ryan K, Shankaran V, Upton MP, Zalcberg J, van de Velde CJ, Tollenaar R; Colorectal Cancer Working Group of the International Consortium for Health Outcomes Measurement (ICHOM).

JAMA Oncol. 2017 May 1;3(5):686-694. doi: 10.1001/jamaoncol.2017.0417.

PMID:
28384684
29.

Adherence to capecitabine in preoperative treatment of stage II and III rectal cancer: do we need to worry?

Font R, Espinas JA, Layos L, Martinez Villacampa M, Capdevila J, Tobeña M, Pisa A, Pericay C, Lezcano C, Fort E, Cardona I, Berga N, Solà J, Borras JM.

Ann Oncol. 2017 Apr 1;28(4):831-835. doi: 10.1093/annonc/mdx006.

PMID:
28327898
30.

Understanding variations in the use of hypofractionated radiotherapy and its specific indications for breast cancer: A mixed-methods study.

Prades J, Algara M, Espinàs JA, Farrús B, Arenas M, Reyes V, García-Reglero V, Cambra MJ, Rubio E, Anglada L, Eraso A, Pedro A, Fuentes-Raspall MJ, Tuset V, Solà J, Borras JM.

Radiother Oncol. 2017 Apr;123(1):22-28. doi: 10.1016/j.radonc.2017.01.014. Epub 2017 Feb 21.

PMID:
28236538
31.

The peritumoural adipose tissue microenvironment and cancer. The roles of fatty acid binding protein 4 and fatty acid binding protein 5.

Guaita-Esteruelas S, Gumà J, Masana L, Borràs J.

Mol Cell Endocrinol. 2018 Feb 15;462(Pt B):107-118. doi: 10.1016/j.mce.2017.02.002. Epub 2017 Feb 3.

PMID:
28163102
32.

Trends in net survival from skin malignant melanoma in six European Latin countries: results from the SUDCAN population-based study.

Galceran J, Uhry Z, Marcos-Gragera R, Borràs J; GRELL EUROCARE-5 Working Group.

Eur J Cancer Prev. 2017 Jan;26 Trends in cancer net survival in six European Latin Countries: the SUDCAN study:S77-S84. doi: 10.1097/CEJ.0000000000000306.

PMID:
28005609
33.

In silico, in vitro and case-control analyses as an effective combination for analyzing BRCA1 and BRCA2 unclassified variants in a population-based sample.

Rodríguez-Balada M, Roig B, Martorell L, Melé M, Salvat M, Vilella E, Borràs J, Gumà J.

Cancer Genet. 2016 Nov;209(11):487-492. doi: 10.1016/j.cancergen.2016.09.003. Epub 2016 Sep 20.

PMID:
27886673
34.

A consensus statement on the gender perspective in lung cancer.

Isla D, Majem M, Viñolas N, Artal A, Blasco A, Felip E, Garrido P, Remón J, Baquedano M, Borrás JM, Die Trill M, García-Campelo R, Juan O, León C, Lianes P, López-Ríos F, Molins L, Planchuelo MÁ, Cobo M, Paz-Ares L, Trigo JM, de Castro J.

Clin Transl Oncol. 2017 May;19(5):527-535. doi: 10.1007/s12094-016-1578-x. Epub 2016 Nov 24. Review.

PMID:
27885542
35.

Estimating long-term crude probability of death among young breast cancer patients: a Bayesian approach.

Clèries R, Buxó M, Yasui Y, Marcos-Gragera R, Martínez JM, Ameijide A, Galceran J, Borràs JM, Izquierdo À.

Tumori. 2016 Dec 1;102(6):555-561. doi: 10.5301/tj.5000545. Epub 2016 Sep 20.

PMID:
27647229
36.

HDL-c levels predict the presence of pleural effusion and the clinical outcome of community-acquired pneumonia.

Saballs M, Parra S, Sahun P, Pellejà J, Feliu M, Vasco C, Gumà J, Borràs JL, Masana L, Castro A.

Springerplus. 2016 Sep 6;5(1):1491. doi: 10.1186/s40064-016-3145-x. eCollection 2016.

37.

Improving survival and local control in rectal cancer in Catalonia (Spain) in the context of centralisation: A full cycle audit assessment.

Manchon-Walsh P, Aliste L, Espinàs JA, Prades J, Guarga A, Balart J, Biondo S, Castells A, Sanjuan X, Tabernero J, Borras JM; Catalonian Rectal Cancer Group.

Eur J Surg Oncol. 2016 Dec;42(12):1873-1880. doi: 10.1016/j.ejso.2016.08.009. Epub 2016 Aug 25.

PMID:
27624916
38.

Reoperations after primary breast conserving surgery in women with invasive breast cancer in Catalonia, Spain: a retrospective study.

Escribà JM, Esteban L, Gálvez J, Pla MJ, Melià A, Gil-Gil M, Clèries R, Pareja L, Sanz X, Bustins M, Borrás JM, Ribes J.

Clin Transl Oncol. 2017 Apr;19(4):448-456. doi: 10.1007/s12094-016-1546-5. Epub 2016 Sep 13.

PMID:
27624712
39.

Demand for radiotherapy in Spain.

Rodríguez A, Borrás JM, López-Torrecilla J, Algara M, Palacios-Eito A, Gómez-Caamaño A, Olay L, Lara PC.

Clin Transl Oncol. 2017 Feb;19(2):204-210. doi: 10.1007/s12094-016-1525-x. Epub 2016 Aug 4. Review.

PMID:
27492014
40.

Experience With Rapid Desensitization to Chemotherapy in a Type B Hospital.

Borras J, El-Qutob D.

J Investig Allergol Clin Immunol. 2016;26(4):271-3. doi: 10.18176/jiaci.0070. No abstract available.

41.

Glioblastoma: does the pre-treatment geometry matter? A postcontrast T1 MRI-based study.

Pérez-Beteta J, Martínez-González A, Molina D, Amo-Salas M, Luque B, Arregui E, Calvo M, Borrás JM, López C, Claramonte M, Barcia JA, Iglesias L, Avecillas J, Albillo D, Navarro M, Villanueva JM, Paniagua JC, Martino J, Velásquez C, Asenjo B, Benavides M, Herruzo I, Delgado MD, Del Valle A, Falkov A, Schucht P, Arana E, Pérez-Romasanta L, Pérez-García VM.

Eur Radiol. 2017 Mar;27(3):1096-1104. doi: 10.1007/s00330-016-4453-9. Epub 2016 Jun 21.

PMID:
27329522
42.

Tumour heterogeneity in glioblastoma assessed by MRI texture analysis: a potential marker of survival.

Molina D, Pérez-Beteta J, Luque B, Arregui E, Calvo M, Borrás JM, López C, Martino J, Velasquez C, Asenjo B, Benavides M, Herruzo I, Martínez-González A, Pérez-Romasanta L, Arana E, Pérez-García VM.

Br J Radiol. 2016 Jul 4:20160242. [Epub ahead of print]

43.

Common variables in European pancreatic cancer registries: The introduction of the EURECCA pancreatic cancer project.

de Leede EM, Sibinga Mulder BG, Bastiaannet E, Poston GJ, Sahora K, Van Eycken E, Valerianova Z, Mortensen MB, Dralle H, Primic-Žakelj M, Borràs JM, Gasslander T, Ryzhov A, Lemmens VE, Mieog JS, Boelens PG, van de Velde CJ, Bonsing BA.

Eur J Surg Oncol. 2016 Sep;42(9):1414-9. doi: 10.1016/j.ejso.2016.03.011. Epub 2016 Mar 28.

PMID:
27061790
44.

Exogenous FABP4 increases breast cancer cell proliferation and activates the expression of fatty acid transport proteins.

Guaita-Esteruelas S, Bosquet A, Saavedra P, Gumà J, Girona J, Lam EW, Amillano K, Borràs J, Masana L.

Mol Carcinog. 2017 Jan;56(1):208-217. doi: 10.1002/mc.22485. Epub 2016 Apr 6.

45.

How many new cancer patients in Europe will require radiotherapy by 2025? An ESTRO-HERO analysis.

Borras JM, Lievens Y, Barton M, Corral J, Ferlay J, Bray F, Grau C.

Radiother Oncol. 2016 Apr;119(1):5-11. doi: 10.1016/j.radonc.2016.02.016. Epub 2016 Feb 24.

46.

Long-term costs of colorectal cancer treatment in Spain.

Corral J, Castells X, Molins E, Chiarello P, Borras JM, Cots F.

BMC Health Serv Res. 2016 Feb 16;16:56. doi: 10.1186/s12913-016-1297-6.

47.

Do we have enough information to act accordingly? The relation between case volume and results revisited again.

Borras JM.

Cir Esp. 2016 Mar;94(3):123-4. doi: 10.1016/j.ciresp.2016.01.001. Epub 2016 Feb 2. English, Spanish. No abstract available.

PMID:
26851135
48.

Improving clinical outcomes through centralization of rectal cancer surgery and clinical audit: a mixed-methods assessment.

Prades J, Manchon-Walsh P, Solà J, Espinàs JA, Guarga A, Borras JM.

Eur J Public Health. 2016 Aug;26(4):538-42. doi: 10.1093/eurpub/ckv237. Epub 2016 Jan 6.

49.

Contribution of changes in demography and in the risk factors to the predicted pattern of cancer mortality among Spanish women by 2022.

Clèries R, Buxó M, Martínez JM, Espinàs JA, Dyba T, Borràs JM.

Cancer Epidemiol. 2016 Feb;40:113-8. doi: 10.1016/j.canep.2015.12.002. Epub 2015 Dec 18.

50.

Psychosocial oncology care resources in Europe: a study under the European Partnership for Action Against Cancer (EPAAC).

Travado L, Reis JC, Watson M, Borràs J.

Psychooncology. 2017 Apr;26(4):523-530. doi: 10.1002/pon.4044. Epub 2015 Dec 21.

PMID:
26685870

Supplemental Content

Loading ...
Support Center